Chemokine receptor antagonism as an approach to anti-inflammatory therapy: ‘just right’ or plain wrong?
- 1 August 2002
- journal article
- review article
- Published by Elsevier in Current Opinion in Chemical Biology
- Vol. 6 (4) , 510-525
- https://doi.org/10.1016/s1367-5931(02)00351-4
Abstract
No abstract availableKeywords
This publication has 172 references indexed in Scilit:
- Chemokines: agents for the immunotherapy of cancer?Nature Reviews Immunology, 2002
- Balanced responsiveness to chemoattractants from adjacent zones determines B-cell positionNature, 2002
- CC Chemokine Receptor (CCR)4 and the CCR10 Ligand Cutaneous T Cell–attracting Chemokine (CTACK) in Lymphocyte Trafficking to Inflamed SkinThe Journal of Experimental Medicine, 2001
- Tumor Necrosis Factor-α-converting Enzyme Mediates the Inducible Cleavage of FractalkineJournal of Biological Chemistry, 2001
- Unique Role of the Chemokine Domain of Fractalkine in Cell CaptureJournal of Biological Chemistry, 2000
- Identification of the Binding Site for a Novel Class of CCR2b Chemokine Receptor AntagonistsPublished by Elsevier ,2000
- Induction of experimental autoimmune encephalomyelitis in C57BL / 6 mice deficient in either the chemokine macrophage inflammatory protein-1α or its CCR5 receptorEuropean Journal of Immunology, 2000
- Function of the chemokine receptor CXCR4 in haematopoiesis and in cerebellar developmentNature, 1998
- The chemokine receptor CXCR4 is essential for vascularization of the gastrointestinal tractNature, 1998
- Mutagenesis Studies of Interleukin-8: IDENTIFICATION OF A SECOND EPITOPE INVOLVED IN RECEPTOR BINDINGPublished by Elsevier ,1996